📈 Analyzing 3,000+ tickers daily — free strategy scores, market data, and a ticker extraction tool. No account required.

TNDM

NASDAQ Healthcare

Tandem Diabetes Care, Inc. - Common Stock

Medical Devices

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

🎯 投资策略评分

TNDM 在各投资策略中的评分。分数越高,越符合该策略目标。

高股息率 + 低波动性
高增长潜力(高贝塔 + 超卖)
逆向投资(超卖 + 低于移动均线)
超买股票(潜在做空标的)
大盘、机构级别股票
🔍 策略解读

最佳匹配: 🚀 Moon Shot (94/100) — 此策略 高增长潜力(高贝塔 + 超卖).

评分最低的策略: 🎈 Over-Hyped (9/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

在文本中查找 TNDM in your text

粘贴任何文章、记录或帖子 — 工具将提取 TNDM 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明:本数据仅供教育和娱乐用途,不构成金融建议。市场数据可能存在延迟。在做出投资决策之前,请始终进行自己的研究。
数据最后更新: 2026-04-17.